source
- STAT+: GLP-1s are given an FDA warning for rare eye condition riskThe FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”STAT · 1d ago↗ source
- Delix raises $100M to advance at-home psychedelic without hallucinogenic effectsThe series C raise, co-led by Johnson & Johnson’s venture capital arm, will help Delix Therapeutics push its novel psychedelic asset into mid-stage development for major depressive disorder.BioSpace · 1d ago↗ source
- Start Center for Cancer Research opens first early-phase clinical trial site in ItalyStart Center for Cancer Research has expanded into Italy, partnering with Istituti Fisioterapici Ospitalieri to open its first early-phase cancer clinical trial site in the country.